# Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

> **NCT02455076** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 150 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Glargine
- **DRUG:** Rapid-acting insulin analogs

## Key facts

- **NCT ID:** NCT02455076
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455076, "Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02455076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*